Evidence map›Paper›PMID 32551684›Full record

ArticleOrganic letters2020

Pyrrole Strategy for the γ-Lactam-Containing

Xianglin Yin, Kaiqing Ma, Ying Dong, Mingji Dai

Open access · greenAbstract read
In one paragraph

Article in Organic letters, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 47 citations in OpenAlex.

  1. Total Synthesis of (±)-Stemocurtisine via Catalytic Carbonylation.Journal of the American Chemical Society · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Xianglin YinDepartment of Chemistry and Center for Cancer Research, Purdue University, West Lafayette, Indiana 47907, United States.
Kaiqing MaDepartment of Chemistry and Center for Cancer Research, Purdue University, West Lafayette, Indiana 47907, United States.
Ying DongDepartment of Chemistry and Center for Cancer Research, Purdue University, West Lafayette, Indiana 47907, United States.
Mingji DaiDepartment of Chemistry and Center for Cancer Research, Purdue University, West Lafayette, Indiana 47907, United States.ORCID 0000-0001-7956-6426
Purdue University West Lafayette · US

Funding

Transgenic Mouse Core Facility Shared Resource (TMCF-SR)P30CA023168 · NCI · PURDUE UNIVERSITY WEST LAFAYETTE · PI John Tesmer · 1985 to 2026
$43.4M
Synthesis and Study of Medicinally Important MoleculesR35GM128570 · NIGMS · PURDUE UNIVERSITY · PI Mingji Dai · 2018 to 2026
$3.7M
NCI NIH HHS P30 CA023168NIGMS NIH HHS R35 GM128570
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AlkaloidsChemistry Techniques, SyntheticHeterocyclic Compounds, 3-RingKineticsLactamsOxidation-ReductionPyrrolesStemonaceaeStereoisomerismAlkaloidsHeterocyclic Compounds, 3-RingLactamsPyrrolesstemoamide

Identifiers

PMID32551684
PMCPMC8232349
OpenAlexW3036594497

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.